Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human FGF13 ELISA Kit (AC3710)
Cat.#: ASET-2299
Specifications
Description Human FGF13 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human FGF13 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 4.04 ng/L Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 50-800 ng/L Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1075 Rat Slit3 ELISA Kit (AC2486) Quantitative inquiry ASET-1337 Mouse Parkin ELISA Kit (AC2748) Quantitative inquiry ASET-1552 Human UNC5C ELISA Kit (AC2963) Quantitative inquiry ASET-2132 Human Mitofusin 2 ELISA Kit (AC3543) Quantitative inquiry ASET-2427 Mouse CD147 ELISA Kit (AC3838) Quantitative inquiry ASET-2059 Human CysLT1 ELISA Kit (AC3470) Quantitative inquiry ASET-1012 Human KCNIP4 ELISA Kit (AC2423) Quantitative inquiry ASET-1131 Human SOX2 ELISA Kit (AC2542) Quantitative inquiry ASET-2080 Human GCLM ELISA Kit (AC3491) Quantitative inquiry ASET-2061 Rat NF-kB p65 ELISA Kit (AC3472) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket